[go: up one dir, main page]

AP2015008640A0 - Vortioxetine manufacturing process - Google Patents

Vortioxetine manufacturing process

Info

Publication number
AP2015008640A0
AP2015008640A0 AP2015008640A AP2015008640A AP2015008640A0 AP 2015008640 A0 AP2015008640 A0 AP 2015008640A0 AP 2015008640 A AP2015008640 A AP 2015008640A AP 2015008640 A AP2015008640 A AP 2015008640A AP 2015008640 A0 AP2015008640 A0 AP 2015008640A0
Authority
AP
ARIPO
Prior art keywords
vortioxetine
manufacturing process
manufacturing
vortioxetine manufacturing
Prior art date
Application number
AP2015008640A
Other languages
English (en)
Inventor
Kim Lasse Christensen
Thomas Ruhland
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AP2015008640A0 publication Critical patent/AP2015008640A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AP2015008640A 2013-02-22 2014-02-20 Vortioxetine manufacturing process AP2015008640A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361767883P 2013-02-22 2013-02-22
DKPA201300104 2013-02-22
PCT/EP2014/053313 WO2014128207A1 (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Publications (1)

Publication Number Publication Date
AP2015008640A0 true AP2015008640A0 (en) 2015-08-31

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2015008640A AP2015008640A0 (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Country Status (38)

Country Link
US (1) US9353073B2 (pl)
EP (1) EP2958903B1 (pl)
JP (1) JP6464098B2 (pl)
KR (1) KR102230628B1 (pl)
CN (1) CN104995181B (pl)
AP (1) AP2015008640A0 (pl)
AU (1) AU2014220735B2 (pl)
BR (1) BR112015019268B1 (pl)
CA (1) CA2901821A1 (pl)
CL (1) CL2015002309A1 (pl)
CR (1) CR20150423A (pl)
CY (1) CY1118883T1 (pl)
DK (1) DK2958903T3 (pl)
DO (1) DOP2015000187A (pl)
EA (1) EA027756B1 (pl)
ES (1) ES2625380T3 (pl)
GE (1) GEP201706749B (pl)
HK (1) HK1216098A1 (pl)
HR (1) HRP20170607T1 (pl)
IL (1) IL240501B (pl)
LT (1) LT2958903T (pl)
MA (1) MA38338B1 (pl)
ME (1) ME02671B (pl)
MX (1) MX362355B (pl)
MY (1) MY172337A (pl)
PE (1) PE20151589A1 (pl)
PH (1) PH12015501807B1 (pl)
PL (1) PL2958903T3 (pl)
PT (1) PT2958903T (pl)
RS (1) RS55932B1 (pl)
RU (1) RU2652265C2 (pl)
SG (1) SG11201506651SA (pl)
SI (1) SI2958903T1 (pl)
SM (1) SMT201700238T1 (pl)
TN (1) TN2015000335A1 (pl)
UA (1) UA116236C2 (pl)
WO (1) WO2014128207A1 (pl)
ZA (1) ZA201506050B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2807419C (en) 2010-08-18 2019-09-24 Sunil Kumar Kc Diketones and hydroxyketones as catenin signaling pathway activators
HUE042001T2 (hu) 2013-02-22 2019-06-28 Samumed Llc Gamma-diketonok Wnt/béta-katenin jelátviteli útvonal aktivátorokként
ES2762559T3 (es) 2014-08-20 2020-05-25 Samumed Llc Gamma-dicetonas para tratamiento y prevención de envejecimiento de la piel y arrugas
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
US20180072690A1 (en) 2015-03-26 2018-03-15 Cipla Limited Methods for Making Serotonin Reuptake Inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
JP6987064B2 (ja) * 2016-02-08 2021-12-22 ハー・ルンドベック・アクチエゼルスカベット 1−[2−(2,4−ジメチル−フェニルスルファニル)−フェニル]ピペラジンの合成
AU2017288456A1 (en) 2016-07-01 2018-12-13 H. Lundbeck A/S Vortioxetine dosing regimes for fast onset of antidepressant effect
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
IL161966A0 (en) * 2001-12-20 2005-11-20 Lundbeck & Co As H Aryloxyphenyl and arylsulfanylphenyl
US8722684B2 (en) * 2006-06-16 2014-05-13 H. Lundbeck A/S 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
CN104995181B (zh) 2017-03-08
PH12015501807A1 (en) 2015-11-09
JP6464098B2 (ja) 2019-02-06
AU2014220735B2 (en) 2017-06-22
CA2901821A1 (en) 2014-08-28
TN2015000335A1 (en) 2017-01-03
AU2014220735A1 (en) 2015-08-20
MA38338A1 (fr) 2016-09-30
HK1216098A1 (zh) 2016-10-14
JP2016509042A (ja) 2016-03-24
PL2958903T3 (pl) 2017-08-31
SG11201506651SA (en) 2015-09-29
RS55932B1 (sr) 2017-09-29
EA201591349A1 (ru) 2015-12-30
CY1118883T1 (el) 2018-01-10
SI2958903T1 (sl) 2017-09-29
SMT201700238T1 (it) 2017-07-18
RU2652265C2 (ru) 2018-04-27
US9353073B2 (en) 2016-05-31
CR20150423A (es) 2015-10-20
KR20150118146A (ko) 2015-10-21
IL240501B (en) 2018-08-30
HRP20170607T1 (hr) 2017-06-30
US20160009670A1 (en) 2016-01-14
DK2958903T3 (en) 2017-05-15
ME02671B (me) 2017-06-20
MX2015010656A (es) 2015-12-17
BR112015019268B1 (pt) 2023-01-10
MX362355B (es) 2019-01-14
DOP2015000187A (es) 2015-11-30
UA116236C2 (uk) 2018-02-26
BR112015019268A2 (pt) 2020-01-28
PT2958903T (pt) 2017-05-26
KR102230628B1 (ko) 2021-03-22
MY172337A (en) 2019-11-21
WO2014128207A1 (en) 2014-08-28
RU2015134407A (ru) 2017-03-28
CL2015002309A1 (es) 2016-03-04
MA38338B1 (fr) 2018-10-31
PE20151589A1 (es) 2015-12-03
ZA201506050B (en) 2017-08-30
GEP201706749B (en) 2017-10-10
IL240501A0 (en) 2015-09-24
CN104995181A (zh) 2015-10-21
ES2625380T3 (es) 2017-07-19
EA027756B1 (ru) 2017-08-31
EP2958903B1 (en) 2017-04-12
PH12015501807B1 (en) 2019-05-31
LT2958903T (lt) 2017-08-25
EP2958903A1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
GB2520596B (en) Manufacturing method
GB201312991D0 (en) Process
HK1216098A1 (zh) 沃替西汀生產方法
GB201321440D0 (en) Process
GB201307334D0 (en) Process
GB201416005D0 (en) Process
GB201322454D0 (en) Process
GB201421426D0 (en) Process
GB201421428D0 (en) Process
GB201401963D0 (en) Process
GB201318888D0 (en) Process
GB201401922D0 (en) Process
GB201322273D0 (en) Process
GB201320869D0 (en) Process
GB201314334D0 (en) Process
GB201307327D0 (en) Process
GB201302441D0 (en) Process
GB201316253D0 (en) Process
GB201307951D0 (en) Process
GB201300073D0 (en) Process
GB2520796B (en) Process
GB201323151D0 (en) Process
GB201303604D0 (en) Manufacturing process
GB201418099D0 (en) Process
GB201319357D0 (en) Process